News
FOCUS has introduced three urinary biomarkers for detection and monitoring of renal injury:
alpha-GST is a cystolic protein highly specific for the cells of the proximal renal tubules. There it is found in high concentrations and is readily released into the urine in the event of renal tubular injury. Urinary alpha-GST is a highly sensitive and specific biomarker of proximal tubular injury.
phi-GST is specific for cells...
FOCUS Clinical Research Center Belgrade, Serbia
Opening of a Strategic Branch in Belgrade, Serbia
In 2007 FOCUS opened a branch in Belgrade, FOCUS Clinical Research Centre Belgrade. It was established in close collaboration with Professor Severovic and the Clinical Centre of Serbia, comprising a team of experts in multiple disease areas and indications. It mainly focuses on Phase I and Proof...
[ more ]Genotyping volunteer populations for clinical trials
FOCUS has conducted an internal genotyping project to investigate in its pool of volunteers clinically significant allele mutations of key drug-metabolizing enzymes. The genotyping data is being compiled in the FOCUS genotype database, which currently contains over hundred volunteers.
Based on a track record in genotyping projects and...
FOCUS CDD offers comprehensive clinical pharmacodynamics services.
Here you find an update on the complete offering for cardiovascular, CNS, metabolic and respiratory disorders (open pdf). For further information please contact Dr. Andreas Schroedter via telephone +49 2131 155 316 or e-mail <LINK...
[ more ]June 2007: FOCUS GmbH has opened an additional 6-8 bed hospital based research unit in the University Clinic of Heinrich Heine University in Dusseldorf, Germany...
The first phase I study has already been performed by the FOCUS staff in this hospital based unit. Due to its full service coverage by the university clinic facilities (medical specialists and ICU team) it will be particularly suitable for First-into-Man studies with high risk compounds.
This new FOCUS unit is only 6 km away from the FOCUS head...
[ more ]


